Runway Growth Finance Corp. — Form 8-K
Filed October 13, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 52/100
What the filing says
Runway Growth funded $8.5M in follow-on investments across four existing portfolio companies in Q3 2026, including a $5.6M restructure into a bridge loan for struggling Marley Spoon SE (which announced 21% workforce reduction). The company received $139.4M in total liquidity events, including full repayments from Extensiv ($72.3M), Route 92 Medical ($35.0M), Onward Medical ($17.1M), and Federal Hearings and Appeals Services ($6.3M), plus $8.7M in other amortization and prepayments. Portfolio stood at 52 debt and 102 equity investments across 42 and 66 companies respectively as of September 30, 2026.
Why this rating
Large capital inflows ($139.4M) exceed company market cap but are normal venture debt repayments; $8.5M new deployment is modest; Marley Spoon distress is offsetting positive signal.
See more from October 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.